S

Sophia Genetics SA
NASDAQ:SOPH

Watchlist Manager
Sophia Genetics SA
NASDAQ:SOPH
Watchlist
Price: 4.75 USD -1.04% Market Closed
Market Cap: 321m USD

Net Margin
Sophia Genetics SA

-102.3%
Current
-129%
Average
1.8%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-102.3%
=
Net Income
-75m
/
Revenue
73.3m

Net Margin Across Competitors

No Stocks Found

Sophia Genetics SA
Glance View

Market Cap
317.4m USD
Industry
Health Care

SOPHiA GENETICS SA is a healthcare technology company, which establishes the practice of data driven medicine as the standard of care and for life sciences research. The firm offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The firm has offices in Switzerland, France and the United Kingdom and operates worldwide.

SOPH Intrinsic Value
4.39 USD
Overvaluation 8%
Intrinsic Value
Price
S
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-102.3%
=
Net Income
-75m
/
Revenue
73.3m
What is the Net Margin of Sophia Genetics SA?

Based on Sophia Genetics SA's most recent financial statements, the company has Net Margin of -102.3%.

Back to Top